iHuman (IH)
(Delayed Data from NYSE)
$1.50 USD
-0.11 (-6.83%)
Updated Aug 5, 2024 03:59 PM ET
After-Market: $1.50 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
IH 1.50 -0.11(-6.83%)
Will IH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IH based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for IH
iHuman Reports Q1 Results and Strategic Growth
iHuman reports Q1 results
IH Stock Earnings: iHuman Reported Results for Q1 2024
iHuman reports Q1 revenue RMB 235M vs. RMB 265.2M last year
iHuman Inc. Announces First Quarter 2024 Unaudited Financial Results